FDAnews Drug Daily Bulletin

Particulate Matter Sparks Baxter Recall

Jan. 12, 2016

Baxter International is voluntarily recalling two lots of intravenous solutions from hospitals due to the potential presence of particulate matter.

Following a customer complaint, an investigation identified the matter as an insect. There have been no adverse events reported to the company. Injecting a product with particulate matter may result in blockage of blood vessels, as well as allergic reactions, local irritation and inflammation in tissues and organs.

Baxter has advised customers not to use 0.9% sodium chloride injection 250 mL and 70% dextrose injection 2,000 mL from affected lots and to return products to the company. The recalled lots were distributed between June 6, 2015 and Dec.16, 2015. Read the recall notice here: www.fdanews.com/01-05-16-BaxterRecall.pdf.